SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cell Genesys (CEGE) -- Ignore unavailable to you. Want to Upgrade?

To: david james who wrote (932)6/5/2000 5:10:00 PM
From: Bosco  Read Replies (2) | Respond to of 1298
 
Hi david, great, thanks. CEGE continues to trade actively after hours. Who knows, I may be able to break even sooner than I thought :)

best, Bosco



To: david james who wrote (932)6/5/2000 6:22:00 PM
From: Gemini  Read Replies (2) | Respond to of 1298
 
David,

I'm listening to the tape. Very close to the beginning,
Sherwin states that the company has approximately 250
million in cash plus an additional 5 million shares of
ABGX (12 percent or about 500 million dollars based upon today's close) or a total of 750 million.

Where does the 250 million come from? I thought the
company had 50 million in actual cash excluding ABGX stock.

Allan


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News